CDC. Acquired immunodeficiency syndrome (AIDS): Precautions for clinical and laboratory staffsMMWR1982 ;31:577-580.
2.
CDC. Acquired immunodeficiency syndrome (AIDS): Precautions for health-care workers and allied professionalsMMWR1983;32:450-451.
3.
CDC. Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in the workplaceMMWR1985;34:681-686, 691-695.
4.
CDC. Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus during invasive proceduresMMWR1986;35:221-223.
5.
CDC. Recommendations for preventing possible transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus from tearsMMWR1985 ;34 :533-534.
6.
CDC. Recommendations for providing dialysis treatment to patients infected with human T-lymphotropic virus type III/ lymphadenopathy-associated virus infectionMMWR1986;35:376-378, 383.
7.
Garner JSS immone BP. Guideline for isolation precautions in hospitalsInfect Control1983;4(suppl):245-325.
8.
CDC. Recommended infection control practices for dentistryMMWR1986 ;35:237-242.
9.
McCray E., The Cooperative Needlestick Surveillance Group. Occupational risk of the acquired immunodeficiency syndrome among health care workersN Engl J Med1986;314:1127-1132.
10.
Henderson DK , Sash AJ, Zak BJ, et al.Risk of nosocomial infection with human T-cell lymphotropic virus type III/lymphadenopathy-associated virus in a large cohort of intensively exposed health care workersAnn Intern Med1986;104:644-647.
11.
Gerberding JL, Bryant-LeBlanc CE, Nelson K., et al.Risk of transmitting the human immunodeficiency virus, cytomegalovirus, and hepatitis B virus to health care workers exposed to patients with AIDS and AIDS-related conditionsJ Infect Dis1987;156: 1-8.
12.
McEvoy M., Porter K., Mortimer P., Simmons N., Shanson D.Prospective study of clinical, laboratory, and ancillary staff with accidental exposures to blood or other body fluids from patients infected with HIVBr Med1987;294:1595-1597.
13.
Anonymous.Needlestick transmission of HTLV-III from a patient infected in AfricaLancet1984;2:1376-1377.
14.
Oksenhendler E., Harzic M., Le Roux JM, Rabian C., Clauvel JPHIV infection with seroconversion after a superficial needlestick injury to the fingerN Engl J Med1986;315:582.
15.
Nelsson-Vernant C., Arfl S., Mathez D., Leibowitch J., Monplaisir N.Needlestick HIV seroconversion in a nurseLancet1986;2: 614.
16.
Grint P., McEvoy M.Two associated cases of the acquired immune deficiency syndrome (AIDS)PHLS Commun Dis Rep1985;42:4.
17.
Cdc.Apparent transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus from a child to a mother providing health careMMWR1986; 35:76-79.
18.
Cdc.Update: Human immunodeficiency virus infections in health-care workers exposed to blood of infected patientsMMWR1987;36:285-289.
19.
Kline RS, Phelan J., Friedland GH, et al.Low occupational risk for HIV infection for dental professionals [Abstract] In; Abstracts from the III International Conference on AIDS. 1-5 June 1985. Washingon, DC: 155.
20.
Baker JL, Kelen GD, Sivertson KT, Quinn TCUnsuspected human immunodeficiency virus in critically ill emergency patientsJAMA1987;257:2609-2611.
21.
Fevero MSDialysis-associated diseases and their control In: Bennett JV, Brachman PS, eds. Hospital Infections.Boston: Little, Brown and Company.1985:267-284.
22.
Richardson JH, Barkley WE, eds. Biosafety in microbiological and biomedical laboratories, 1984. Washington, DC: US Department of Health and Human Services, Public Health Service. HHS publication no. (CDC) 84-8395.
Environmental Protection Agency.EPA guide for infectious waste managementWashington, DC: U.S. Environmental Protection Agency, May 1986 (Publication no. EPA/530-SW-86-014).
25.
Favero MSSterilization, disinfection, and antisepsis in the hospital In: Monual of Clinical Microbiology. 4th ed. Washington, DC: American Society for Microbiology, 1985;129-137.
26.
Garner JS, Favero MSGuideline for hand-washing and hospital environmental control, 1985Atlanta: Public Health Service, Centers for Disease Control, 1985. HHS publication no. 99-1117.
27.
Spire B., Montagnier L., Barré-Sinoussi F., Chermann JCInactivation of lymphadenopathy associated virus by chemical disinfectantsLancet1984;2:899-901.
28.
Martin LS, McDougal JS, Loskoski SLDisinfection and inactivation of the human T lymphotropic virus type III/lymphadenopathy-associated virusJ Infect Dis1985;152: 400-403.
29.
McDougal JS , Martin LS, Cort SP, et al.Thermal inactivation of the acquired immunodeficiency syndrome virus-III/lymphadenopathy-associated virus, with special reference to antihemophilic factorJ Clin Invest1985;76:875-877.
30.
Spire B., Barré-Sinoussi F., Dormont D., Montagnier L., Chermann JCInactivation of lymphadenopathy-associated virus by heat, gamma rays, and ultraviolet lightLancet1985;1:188-189.
31.
Resnik L., Veren K., Salahuddin SZ, Tondreau S., Markham PDStability and inactivation of HTLV-III/LAV under clinical and laboratory environmentsJAMA1986;255: 1887-1891.
32.
Cdc.Public Health Service (PHS) guidelines for counseling and antibody testing to prevent HIV infection and AIDSMMWR1987;3:509-515.
33.
Kane MA, Lattau LATransmission of HBV from dental personnel to patientsJ Am Dent Assoc1985;110:634-636.
34.
Lettau LA, Smith JD, Williams D., et al.Transmission of hepatitis B with resultant restriction of surgical practiceJAMA1986; 255:934-937.
35.
Williams WWGuideline for infection control in hospital personnelInfect Control1983;4(suppl):326-349.
36.
Cdc.Prevention of acquired immune deficiency syndrome (AIDS): Report of Inter-agency recommendationsMMWR1983;32: 101-103.
37.
Cdc.Provisional Public Health Service Inter-agency recommendations for screening donated blood and plasma for antibody to the virus causing acquired immunodeficiency syndromeMMWR1985;34:1-5.